Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Metformin: an antiproliferative agent and methylation regulator in treating prostatic disease?

Wang Z, Olumi AF. Metformin: an antiproliferative agent and methylation regulator in treating prostatic disease? Am J Physiol Renal Physiol. 2018 03 01; 314(3):F407-F411.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.